Literature DB >> 26867527

Characterizing airflow profile in the postoperative maxillary sinus by using computational fluid dynamics modeling: A pilot study.

Kevin J Choi1, David W Jang, Matthew D Ellison, Dennis O Frank-Ito.   

Abstract

BACKGROUND: Maxillary antrostomy is commonly performed during endoscopic sinus surgery. Little is known about the association surrounding recalcitrant maxillary sinusitis, antrostomy size, and intranasal airflow changes. Furthermore, the interaction between sinus mucosa and airflow is poorly understood. This study used computational fluid dynamics (CFD) modeling to investigate postoperative airflow characteristics between diseased and nondiseased maxillary sinuses in subjects with recurrent disease.
METHODS: A retrospective review of patients from a tertiary-level academic rhinology practice was performed. Seven subjects with endoscopic evidence of postoperative maxillary sinus disease that presented as chronic unilateral crusting at least 1 year after bilateral maxillary antrostomies were selected. A three-dimensional model of each subject's sinonasal cavity was created from postoperative computed tomographies and used for CFD analysis.
RESULTS: Although the variables investigated between diseased and nondiseased sides were not statistically significant, the diseased side in six subjects had a smaller antrostomy, and five of these subjects had both reduced nasal unilateral airflow and increased unilateral nasal resistance on the diseased side. The ratio of posterior wall shear stress (WSS) of the maxillary sinus to the total WSS was higher on the diseased side in six subjects. Results also showed strong correlations between antrostomy and CFD variables on the diseased side than on the nondiseased side.
CONCLUSION: This pilot study showed that the majority of the simulated sinonasal models exhibited common characteristics on the side with persistent disease, such as smaller antrostomy, reduced nasal airflow, increased nasal resistance, and increased posterior WSS. Although statistical significance was not established, this study provided preliminary insight into variables to consider in a larger cohort study.

Entities:  

Mesh:

Year:  2016        PMID: 26867527     DOI: 10.2500/ajra.2016.30.4266

Source DB:  PubMed          Journal:  Am J Rhinol Allergy        ISSN: 1945-8932            Impact factor:   2.467


  6 in total

1.  Investigating the effects of laryngotracheal stenosis on upper airway aerodynamics.

Authors:  Tracy Cheng; David Carpenter; Seth Cohen; David Witsell; Dennis O Frank-Ito
Journal:  Laryngoscope       Date:  2017-10-17       Impact factor: 3.325

2.  A hierarchical stepwise approach to evaluate nasal patency after virtual surgery for nasal airway obstruction.

Authors:  Dennis O Frank-Ito; Julia S Kimbell; Azadeh A T Borojeni; Guilherme J M Garcia; John S Rhee
Journal:  Clin Biomech (Bristol, Avon)       Date:  2018-12-19       Impact factor: 2.063

3.  A systematic analysis of surgical interventions for the airway in the mature unilateral cleft lip nasal deformity: a single case study.

Authors:  Rose T Tillis; Reanna Shah; Hannah L Martin; Alexander C Allori; Jeffrey R Marcus; Dennis O Frank-Ito
Journal:  Int J Comput Assist Radiol Surg       Date:  2021-06-02       Impact factor: 2.924

4.  Computational Analysis of the Mature Unilateral Cleft Lip Nasal Deformity on Nasal Patency.

Authors:  Dennis O Frank-Ito; David J Carpenter; Tracy Cheng; Yash J Avashia; David A Brown; Adam Glener; Alexander Allori; Jeffrey R Marcus
Journal:  Plast Reconstr Surg Glob Open       Date:  2019-05-16

Review 5.  The microbiome of the upper respiratory tract in health and disease.

Authors:  Christina Kumpitsch; Kaisa Koskinen; Veronika Schöpf; Christine Moissl-Eichinger
Journal:  BMC Biol       Date:  2019-11-07       Impact factor: 7.431

6.  Orally Inhaled Drug Particle Transport in Computerized Models of Laryngotracheal Stenosis.

Authors:  Dennis Onyeka Frank-Ito; Seth Morris Cohen
Journal:  Otolaryngol Head Neck Surg       Date:  2020-10-13       Impact factor: 3.497

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.